Literature DB >> 7110127

Kinetic properties of human muscle pyruvate kinase.

B Baranowska, T Baranowski.   

Abstract

The steady-state kinetics of human skeletal muscle pyruvate kinase (MA) and its RNA-complex (MB) has been examined and compared. Kinetic studies revealed significant differences in kinetic properties with respect to free and complex form of pyruvate kinase. The MA form follows a simple Michaelis-Menten kinetics in contrast with the MB form, which displays a negative cooperativity with respect to ADP. Vmax for the complex is 40-60% that for free enzyme. Heterologous RNA is a noncompetitive inhibitor of free enzyme but the kinetics of the complex (MB) is not affected. In presence of 1.0 mM ATP in an assay mixture the kinetic constants of the complex were unchanged except for Vmax, which increased by nearly 60%. Aged preparations of free enzyme (MA) were activated by 100% and more, but the native enzyme was inhibited by 22%. Inorganic phosphate is a potent activator of both forms of pyruvate kinase. In presence of 50 mM K-phosphate the apparent Michaelis constant and interaction coefficient are unchanged, but Vmax for free enzyme increases by 35% and for the complex by 70%, respectively. The specific activity of aged MA form can be restored to the original value after incubation of the enzyme in 50 mM K-phosphate, pH 7.6, or by addition of ATP (1.0 mM) to the assay mixture.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110127     DOI: 10.1007/BF00223506

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  9 in total

1.  Kinetic studies of the activation of creatine-phosphoryltransferase by magnesium.

Authors:  J F MORRISON; A G OGSTON
Journal:  Biochim Biophys Acta       Date:  1961-09-02

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Pyruvate kinase from human skeletal muscle.

Authors:  B Baranowska; T Baranowski
Journal:  Mol Cell Biochem       Date:  1975-03-27       Impact factor: 3.396

4.  The control by RNA of pyruvate kinase activity in human skeletal muscle.

Authors:  B Baranowska; T Baranowski
Journal:  Mol Cell Biochem       Date:  1977-05-31       Impact factor: 3.396

5.  Ribonucleoprotein complexes of pyruvate kinase from human skeletal muscle.

Authors:  B Baranowska; T Baranowski
Journal:  Mol Cell Biochem       Date:  1977-09-09       Impact factor: 3.396

Review 6.  Enzymic phosphoryl group transfer.

Authors:  J F Morrison; E Heyde
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

7.  The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters.

Authors:  R Eisenthal; A Cornish-Bowden
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

8.  Studies on the inhibition of ATP: creatine phosphotransferase by NaCl.

Authors:  E Heyde; J F Morrison
Journal:  Biochim Biophys Acta       Date:  1970-08-15

9.  Conformers of pyruvate kinase from human skeletal muscle.

Authors:  B Baranowska; T Baranowski
Journal:  Bull Acad Pol Sci Biol       Date:  1977
  9 in total
  2 in total

1.  Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.

Authors:  Roya Zoraghi; Raymond H See; Peter Axerio-Cilies; Nag S Kumar; Huansheng Gong; Anne Moreau; Michael Hsing; Sukhbir Kaur; Richard D Swayze; Liam Worrall; Emily Amandoron; Tian Lian; Linda Jackson; Jihong Jiang; Lisa Thorson; Christophe Labriere; Leonard Foster; Robert C Brunham; William R McMaster; B Brett Finlay; Natalie C Strynadka; Artem Cherkasov; Robert N Young; Neil E Reiner
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

2.  The influence of inorganic phosphate and ATP on the kinetics of bovine heart muscle pyruvate kinase.

Authors:  B Baranowska; G Terlecki; T Baranowski
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.